journal article·2026-05

Polycaprolactone/retinoic acid/nano-hydroxyapatite composites for neural tissue engineering

Pegah Madaninasab, Mehdi Ebrahimian-Hosseinabadi, Anousheh Zargar Kharazi

Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Graphene and Nanomaterials Applications · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (95)

Show source-provided references
1. The need for engineering neural tissue using stem cells
2. Fabrication and evaluation of a nerve guidance conduit capable of Ca 2+ ion release to accelerate axon extension in peripheral nerve regeneration10.1002/jbm.a.36425 ↗
3. Novel gene therapy approaches for targeting neurodegenerative disorders: focusing on delivering neurotrophic genes10.1007/s12035-024-04260-y ↗
4. Exosomes as biomarkers and therapeutic agents in neurodegenerative diseases: current insights and future directions10.1007/s12035-025-04825-5 ↗
5. Current and novel polymeric biomaterials for neural tissue engineering10.1186/s12929-018-0491-8 ↗
6. Synthetic biomaterials for engineering neural tissue from stem cells
7. Development of a glial cell-derived neurotrophic factor-releasing artificial dura for neural tissue engineering applications10.1039/C5TB00871A ↗
8. Biocompatible PCL-nanofibers scaffold with immobilized fibronectin and laminin for neuronal tissue regeneration10.1016/j.msec.2020.111550 ↗
9. Electrospun nanofibrous scaffolds of polycaprolactone/gelatin reinforced with layered double hydroxide nanoclay for nerve tissue engineering applications10.1021/acsomega.2c02863 ↗
10. Manufacturing of polycaprolactone - graphene fibers for nerve tissue engineering10.1016/j.jmbbm.2019.103387 ↗
11. Development and evaluation of BDNF-loaded PCL/PVA two-layer nerve guidance conduit with enhanced biomechanical and biological properties for peripheral nerve regeneration10.1016/j.heliyon.2025.e42792 ↗
12. Meningeal-derived retinoic acid regulates neurogenesis via suppression of notch and Sox 210.1016/j.celrep.2025.115637 ↗
13. Multifunctional electrospun scaffolds for promoting neuronal differentiation of induced pluripotent stem cells10.1166/jbt.2014.1223 ↗
14. Retinoic acid –loaded core-shell fibrous scaffold for neuronal differentiation of trabecular mesenchymal stem cells
15. Effects of lamellar microstructure of retinoic acid loaded-matrixes on physicochemical properties, migration, and neural differentiation of P19 embryonic carcinoma cells10.1515/polyeng-2020-0009 ↗
16. Nanostructured bioceramics and applications
17. Neuronal calcium signaling: function and dysfunction10.1007/s00018-013-1550-7 ↗
18. Study of nanohydroxyapatite coatings prepared by the electrophoretic deposition method at various voltage and time parameters10.3390/ma17102242 ↗
19. Fabrication and characterization of polycaprolactone/chitosan—hydroxyapatite hybrid implants for peripheral nerve regeneration10.3390/polym13050775 ↗
20. Assessing physicochemical, mechanical, and in vitro biological properties of polycaprolactone/poly(glycerol sebacate)/hydroxyapatite composite scaffold for nerve tissue engineering10.1016/j.matchemphys.2021.125224 ↗
21. Hydroxyapatite nanorods function as safe and effective growth factors regulating neural differentiation and neuron development
22. Research and application of conductive nanofiber nerve guidance conduits for peripheral nerve regeneration: a narrative review
23. Enhancement of synthesis of extracellular matrix proteins on retinoic acid loaded electrospun scaffolds10.1039/C8TB01244J ↗
24. Investigating how all‐trans retinoic acid polycaprolactone (atRA‐PCL) microparticles alter the material properties of 3D printed fibrin constructs10.1002/mabi.202400464 ↗
25. Optimum parameters for the production of nano-scale electrospun polycaprolactone to be used as a biomedical material10.1088/2043-6254/aa92b4 ↗
26. Enhancing the electrical conductivity of electrospun PCL fibers by coating with polydopamine and in situ gold nanoparticles doped on the polydopamine coating10.3390/polym17233192 ↗
27. Morphology and properties of electrospun PCL and its composites for medical applications: a mini review10.3390/app9112205 ↗
28. Nano-hydroxyapatite-incorporated polycaprolactone nanofibrous scaffold as a dentin tissue engineering-based strategy for vital pulp therapy10.1016/j.dental.2022.03.006 ↗
29. Mechanical and dielectric properties of aligned electrospun fibers10.3390/fib9010004 ↗
30. Study of the in vitro degradation and characterization of the HaCat keratinocytes adherence on electrospun scaffolds based polyvinyl alcohol/sodium alginate10.1002/app.52775 ↗
31. Stability and acidic pH-mediated leakage of guest molecules from self-assembly of poly(amidoamine)-graft-alkyl copolymers10.1016/j.polymer.2019.121894 ↗
32. Ginsenosides attenuate bioenergetics and morphology of mitochondria in cultured PC12 cells under the insult of amyloid beta-peptide10.1016/j.jgr.2020.09.005 ↗
33. PC12 differentiation to neuron cells activated by a low-level laser at 660 nm on UV pre-treated CR-39 scaffolds with parallel microchannels10.1364/BOE.530876 ↗
34. Use of phosphorodithioate-based compounds as hydrogen sulfide donors10.1016/bs.mie.2014.11.032 ↗
35. Effect of fiber diameter on proliferation and differentiation of MC3T3-E1 pre-osteoblasts10.1166/jbt.2017.1548 ↗
36. Characterization and physical properties of electrospun gelatin nanofibrous films by incorporation of nano-hydroxyapatite10.1016/j.foodhyd.2019.105640 ↗
37. Analysis and prediction of the diameter and orientation of AC electrospun nanofibers by response surface methodology10.1016/j.matdes.2020.108902 ↗
38. Electrospun nanofibrous filtration membranes for heavy metals and dye removal
39. Electrospun preparation and biological properties in vitro of polyvinyl alcohol/sodium alginate/nano-hydroxyapatite composite fiber membrane10.1016/j.colsurfb.2018.09.074 ↗
40. Evaluation of morphology and cell behaviour of a novel synthesized electrospun poly(vinyl pyrrolidone)/poly(vinyl alcohol)/hydroxyapatite nanofibers
41. Electrospinning of nano/micro scale poly(l-lactic acid) aligned fibers and their potential in neural tissue engineering10.1016/j.biomaterials.2004.06.051 ↗
42. A review of electrospinning manipulation techniques to direct fiber deposition and maximize pore size10.1515/esp-2017-0002 ↗
43. Influence of nanofiber orientation on morphological and mechanical properties of electrospun chitosan mats10.1155/2018/3651480 ↗
44. Electrospun fiber membranes enable proliferation of genetically modified cells10.2147/IJN.S40117 ↗
45. Electrospun polycaprolactone fibrous membranes containing Ag, TiO2 and Na2Ti6O13 particles for potential use in bone regeneration10.3390/membranes9010012 ↗
46. Synthesis and biocompatibility evaluation of PCL electrospun membranes coated with MTA/HA for potential application in dental pulp capping10.3390/polym14224862 ↗
47. Preparation of all-trans retinoic acid nanosuspensions using a modified precipitation method10.1080/03639040500534184 ↗
48. Current utility of arbuscular mycorrhizal fungi and hydroxyapatite nanoparticles in suppression of tomato root-knot nematode10.3390/agronomy12030671 ↗
49. Fabrication and characterization of polycaprolactone with retinoic acid and cerium oxide for anticancer applications10.33263/BRIAC133.201 ↗
50. Synthesis and characterization of curcumin loaded PLA—Hyperbranched polyglycerol electrospun blend for wound dressing applications10.1016/j.msec.2017.03.200 ↗
51. PCL-based composite scaffold matrices for tissue engineering applications10.1007/s12033-018-0084-5 ↗
52. The effect of crystalline morphology on the degradation of polycaprolactone in a solution of phosphate buffer and lipase10.1002/pat.1227 ↗
53. Polymeric biomaterials as tissue scaffolds
54. Hydrolytic degradation of porous crosslinked Poly(ε-Caprolactone) synthesized by high internal phase emulsion templating10.3390/polym12081849 ↗
55. Hydrolytic degradation and bioactivity of electrospun PCL-Mg-NPs fibrous mats10.3390/molecules28031001 ↗
56. Tuning polycaprolactone degradation for long acting implantables10.1016/j.polymer.2022.125473 ↗
57. In vitro and in vivo evaluation of rotary-jet-spun poly(ɛ-caprolactone) with high loading of nano-hydroxyapatite10.1007/s10856-019-6222-1 ↗
58. In vitro degradation of PLLA/nHA composite scaffolds10.1002/pen.23806 ↗
59. In vitro and in vivo degradation of non-woven materials made of poly(ε-caprolactone) nanofibers prepared by electrospinning under different conditions10.1163/156856205774576655 ↗
60. Biomaterials for neural tissue engineering10.3389/fnano.2021.643507 ↗
61. Synthesis and characterization of nano-biocomposite (PMMA-hydroxyapatite - CaZrO3) for bone tissue engineering
62. The effect of nanohydroxyapatite and silver nanoparticles on the microhardness and surface roughness of composite resin
63. Effect of nano-hydroxyapatite on protein adsorption and cell adhesion of poly(lactic acid)/nano-hydroxyapatite composite microspheres10.1007/s42452-020-2531-8 ↗
64. In vitro degradation behaviour of hybrid electrospun scaffolds of polycaprolactone and strontium-containing hydroxyapatite microparticles10.1016/j.polymdegradstab.2019.06.017 ↗
65. Advances and challenges in retinoid delivery systems in regenerative and therapeutic medicine10.1038/s41467-020-18042-2 ↗
66. Biodegradable poly-epsilon-caprolactone (PCL) for tissue engineering applications: a review
67. In vitro and in vivo evaluation of electrospun cellulose acetate/gelatin/hydroxyapatite nanocomposite mats for wound dressing applications10.1080/21691401.2018.1439842 ↗
68. Tissue stiffness dictates development, homeostasis, and disease progression10.1080/15476278.2015.1019687 ↗
69. Long-term stability strategies of deep brain flexible neural interface10.1038/s41528-025-00410-x ↗
70. A review of powder deposition in additive manufacturing by powder bed fusion10.1016/j.jmapro.2021.12.021 ↗
71. Increase the elongation at break of poly (lactic acid) composites for use in food packaging films10.1038/srep46767 ↗
72. Plasticization effects of PEG of low molar fraction and molar mass on the molecular dynamics and crystallization of PLA- b -PEG- b -PLA triblock copolymers envisaged for medical applications10.1021/acs.jpcb.5c00171 ↗
73. Biocompatibility evaluation of nano-hydroxyapatite modified hydroxypropyl methylcellulose/polyvinylpyrrolidone blends10.1007/s00289-023-04870-x ↗
74. A review of the effect of plasticizers on the physical and mechanical properties of alginate-based films10.3390/molecules28186637 ↗
75. Plasticizer design strategies enabling advanced applications of cellulose acetate10.1016/j.eurpolymj.2023.112360 ↗
76. Nano-hydroxyapatite/natural polymer composite scaffolds for bone tissue engineering: a brief review of recent trend10.1007/s44164-023-00049-w ↗
77. Mechanical properties and corrosion behavior of powder metallurgy iron-hydroxyapatite composites for biodegradable implant applications10.1016/j.matdes.2016.07.092 ↗
78. Effect of hydroxyapatite filler concentration on mechanical properties of poly (methyl methacrylate) denture base10.1007/s42452-020-2546-1 ↗
79. A predictive model towards understanding the effect of reinforcement agglomeration on the stiffness of nanocomposites10.1177/00219983221076639 ↗
80. Transverse elasticity and blood perfusion of sciatic nerves under in situ circular compression10.1016/j.jbiomech.2004.10.026 ↗
81. Fabrication and in-vitro experimental study on an implantable controlled drug delivery system with micro-hole for zero-order release10.1088/2053-1591/abaf17 ↗
82. 3D printing of tunable zero-order release printlets10.3390/polym12081769 ↗
83. A drug carrier for sustained zero-order release of peptide therapeutics10.1038/s41598-017-05898-6 ↗
84. Cell proliferation and cytotoxicity assays10.2174/1389201017666160808160513 ↗
85. The impact of contact angle on the biocompatibility of biomaterials10.1097/OPX.0b013e3181da863e ↗
86. Anticancer properties of platinum nanoparticles and retinoic acid: combination therapy for the treatment of human neuroblastoma cancer10.3390/ijms21186792 ↗
87. Functionalization of electrospun nanofibers and fiber alignment enhance neural stem cell proliferation and neuronal differentiation10.3389/fbioe.2020.580135 ↗
88. Cell-electrospinning and its application for tissue engineering10.3390/ijms20246208 ↗
89. Preparation of bioactive hydroxyapatite@halloysite and its effect on MC3T3-E1 osteogenic differentiation of chitosan film10.1016/j.msec.2019.110072 ↗
90. The multifaceted role of calcium signaling dynamics in neural cell proliferation and gliomagenesis10.3934/biophy.2024017 ↗
91. Nanostructured biomaterials for regeneration10.1002/adfm.200800662 ↗
92. The role of extracellular matrix (ECM) adhesion motifs in functionalised hydrogels10.3390/molecules28124616 ↗
93. Challenges and strategies for in situ endothelialization and long-term lumen patency of vascular grafts
94. Self-assembled biodegradable nanoparticles and polysaccharides as biomimetic ECM nanostructures for the synergistic effect of RGD and BMP-2 on bone formation
95. Physical properties of zinc, silver, or cerium ion doped borate glass incorporated PCL/gelatin electrospun fibers and their interaction with NG108-15 neural cells10.1007/s10856-025-06863-w ↗